Paul Tudor Jones Precigen, Inc. Transaction History

Tudor Investment Corp Et Al

$25.1 Billion
Q4 2024

A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Precigen, Inc. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 71,464 shares of PGEN stock, worth $137,925. This represents 0.0% of its overall portfolio holdings.

Number of Shares

71,464

Previous 71,464 -0.0%

Holding current value

$137,925

Previous $67,000 19.4%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.88 - $2.19 $22,296 - $55,488	-25,337 Reduced 26.17%	71,464 $76,000
Q4 2022 Feb 14, 2023	BUY	$1.27 - $2.26 $29,165 - $51,900	22,965 Added 31.1%	96,801 $147,000
Q3 2022 Nov 14, 2022	BUY	$1.41 - $2.79 $62,563 - $123,795	44,371 Added 150.59%	73,836 $157,000
Q2 2022 Aug 15, 2022	SELL	$1.15 - $2.53 $57,475 - $126,446	-49,979 Reduced 62.91%	29,465 $39,000
Q1 2022 May 16, 2022	BUY	$1.91 - $3.98 $151,738 - $316,187	79,444 New	79,444 $168,000
Q4 2021 Feb 14, 2022	SELL	$3.53 - $5.5 $432,979 - $674,613	-122,657 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$4.99 - $6.55 $522,198 - $685,450	104,649 Added 581.13%	122,657 $612,000
Q2 2021 Aug 16, 2021	SELL	$6.24 - $8.22 $108,688 - $143,175	-17,418 Reduced 49.17%	18,008 $117,000
Q1 2021 May 17, 2021	SELL	$6.74 - $10.95 $119,816 - $194,658	-17,777 Reduced 33.41%	35,426 $244,000
Q4 2020 Feb 16, 2021	SELL	$3.75 - $10.56 $142,800 - $402,124	-38,080 Reduced 41.72%	53,203 $543,000
Q3 2020 Nov 16, 2020	BUY	$3.5 - $6.2 $46,539 - $82,441	13,297 Added 17.05%	91,283 $319,000
Q2 2020 Aug 14, 2020	BUY	$2.16 - $5.46 $142,588 - $360,430	66,013 Added 551.35%	77,986 $389,000
Q1 2020 May 15, 2020	SELL	$1.46 - $7.19 $34,996 - $172,344	-23,970 Reduced 66.69%	11,973 $41,000
Q4 2019 Feb 14, 2020	BUY	$5.01 - $6.58 $180,074 - $236,504	35,943 New	35,943 $197,000

Others Institutions Holding PGEN

# of Institutions

144

Shares Held

160M

Call Options Held

136K

Put Options Held

4.8K

View Full List

About PRECIGEN, INC.

Ticker PGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 208,150,000
Market Cap $402M
Description
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...

More about PGEN

Track Paul Tudor Jones's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.

Account